This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Johnson & Johnson (JNJ)

NYSE: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 14.52B 20.93B 14.91B 24.54B
Receivables 10.98B 11.71B 11.31B 10.58B
Inventories 8.18B 7.88B 7.50B 6.28B
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 59.31B 56.41B 46.12B 54.32B
Property, Plant & Equipment, Gross 36.68B 37.13B 34.65B 31.83B
Accumulated Depreciation & Depletion 20.56B 20.42B 18.56B 17.09B
Property, Plant & Equipment, Net 16.13B 16.71B 16.10B 14.74B
Intangibles 27.22B 27.95B 28.75B 18.14B
Other Non-Current Assets 3.23B 4.95B 3.42B 3.77B
Total Non-Current Assets 71.81B 76.28B 75.23B 59.33B
Liabilities & Shareholder Equity
Total Assets 131.12B 132.68B 121.35B 113.64B
Accounts Payable 7.63B 6.27B 5.83B 5.72B
Short Term Debt 3.64B 4.85B 4.68B 6.66B
Other Current Liabilities 500.00M 770.00M 1.06B 854.00M
Total Current Liabilities 25.08B 25.68B 24.26B 22.81B
Long Term Debt 15.12B 13.33B 11.49B 12.97B
Deferred Income Taxes 3.15B 3.99B 3.14B 1.80B
Other Non-Current Liabilities 18.01B 15.64B 17.63B 18.98B
Minority Interest 0.00 0.00 -339.00M 0.00
Total Non-Current Liabilities 36.28B 32.96B 32.26B 33.75B
Total Liabilities 61.37B 58.63B 56.52B 56.56B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 69.75B 74.05B 64.83B 57.08B
Common Par 3.12B 3.12B 3.12B 3.12B
Additional Paid In Capital 0.00 0.00 0.00 0.00
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 97.24B 89.49B 85.99B 81.25B
Treasury Stock -19.89B -15.70B -18.48B -21.66B
Other Equity Adjustments -10.72B -2.86B -5.81B -5.63B
Total Capitalization 84.87B 87.38B 76.32B 70.05B
Total Equity 69.75B 74.05B 64.83B 57.08B
Total Liabilities & Stock Equity 131.12B 132.68B 121.35B 113.64B
Total Common Shares Outstanding 2.78B 2.82B 2.80B 2.72B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 336.62M 299.22M 341.35M 395.48M
Basic Weighted Shares Outstanding 2.82B 2.81B 2.75B 2.74B
Diluted Weighted Shares Outstanding 2.86B 2.88B 2.81B 2.78B
Number of Employees 126500 128100 127600 117900
Number of Part-Time Employees 0 0 0 0
JNJ News

JNJ Johnson & Johnson

Analysts Ratings for JNJ

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 5 5
Moderate Buy 3 3 3 3
Hold 7 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

JNJ Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs